ROME founder Rosana Kapeller re­cruits a CSO from the se­nior ranks of a ma­jor league R&D team

The phone call start­ed in­no­cent­ly enough.

Den­nis Za­ller, then the ex­ec­u­tive di­rec­tor for in­te­gra­tive sci­ences at Cel­gene/BMS, rang up Rosana Kapeller back in April to con­grat­u­late her on the $50 mil­lion Se­ries A for her new biotech, ROME Ther­a­peu­tics. The two had col­lab­o­rat­ed a few times when Kapeller worked for Nim­bus, and Za­ller, do­ing his due dili­gence, want­ed to see if the new start­up could be a fit for a new part­ner­ship.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER